Navigation Links
Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
Date:4/28/2010

BOCA RATON, Fla. April 28 /PRNewswire/ -- The X-GRAFT™ device is fashioned from solid human cortical bone, and is designed to acutely treat degenerative conditions of the spine. Utilizing the benefits of a minimal-exposure surgical procedure, the X-GRAFT™ is implanted into the interspinous space to provide stabilization of the spine, with minimal disturbance to the surrounding tissue. This is the first to market in a series of minimally invasive devices currently in development at Binder Biomedical and a key component of the MLIFF™ (Minimal - Lumbar, Interspinous, Facet Fusion) procedure.

Lawrence Binder, President of Binder Biomedical, Inc. commented: "The robust patent-pending design of the X-GRAFT™ device makes it an excellent option for stabilization of the lumbar spine following a decompression. The benefits of this system are evident from the favorable feedback we've received from our users. By offering a full range of sizes, as well as a comprehensive set of precision instruments, the X-GRAFT™ device has the unique ability to accommodate varying patient anatomy, while using minimal exposure, and fewer steps than traditional techniques."

The X-GRAFT™ device is procured and manufactured to exacting specifications by the University of Miami Tissue Bank (UMTB). This non-profit organization is the first civilian tissue bank in the U.S. and a university owned and operated tissue bank. UMTB is a comprehensive world-class facility, which conducts rigorous screening, recovery, autopsies, processing and packaging for all donors. Implantation of the 100th X-GRAFT™ is expected by the end of next month. Plans to expand national distributions are already underway, along with a full launch of the X-GRAFT™ device a
'/>"/>

SOURCE Binder Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
2. Competitive Technologies Selects RF
3. Binder as Public Relations Agency of Record
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... completed the acquisition of leading OTC brands from GSK ... The transaction is a clear demonstration of Perrigo,s unique ... European distribution network spanning 36 countries.  ... commented, "We are excited to complete this transaction, ...
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
(Date:8/28/2015)... LONDON , August 28, 2015 ... approach seamlessly connects people, technologies and care ... improving outcomes and the cost of healthcare delivery ... AEX: PHIA) today announced its presence at  ESC Congress 2015 , ... Heart Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that connect ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4
... Ridge Diagnostics, Inc., a neurodiagnostic company, announced that ... test for Major Depressive Disorder(MDD), will be presented during ... to Aid in Diagnosis, Treatment and Management of Major ... Meeting, May 20, 2009. The blood test, for the ...
... ATLANTA, May 20 /PRNewswire-FirstCall/ -- ... an Atlanta-based, publicly traded biopharmaceutical company developing human ... Virus) and other infectious agents, announced today that ... band Styx, has joined the GeoVax Labs awareness ...
Cached Medicine Technology:Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression Presented at American Psychiatric Association Annual Meeting 2Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine 2Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine 3Chuck Panozzo, Founder of Rock Band Styx, Joins GeoVax Labs, Inc. as an Advocate for Its HIV/AIDS Vaccine 4
(Date:8/28/2015)... ... August 28, 2015 , ... ... Day at the Zoo to celebrate children helping children, a thank you to ... throughout West Ohio have contributed to the United Methodist initiative to end malaria ...
(Date:8/28/2015)... Angeles, CA (PRWEB) , ... August 28, 2015 , ... ... endless journey that local pizza maker Paul LaRocco has gone through to open a ... city approval and permitting process tends to take several months, but the current process, ...
(Date:8/28/2015)... ... 28, 2015 , ... For Dallas, the time is nearing for the annual ... Tenet Health. , The American Heart Association hosts their well-known Heart Walk to raise ... together, a difference can be made. Walkers can participate in the cause and someone ...
(Date:8/28/2015)... ... 2015 , ... As reported by Medical Daily on August 22 , ... that last for two years, the longest of any cellulite reduction system currently on ... a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, director of ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, a ... “Music With A Mission” benefit concert in Mendon, IL. Held in the Show Barn ... to support music education programs in the underfunded local school districts of Mendon at ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... Beth Israel Deaconess,Medical Center audit, BOSTON, Feb. 6 ... apply the same Sarbanes-Oxley,standards used by Boston Properties and ... of Beth Israel Deaconess Medical Center (BIDMC),according to labor ... the president and CFO of Boston Properties., 1199 ...
... The Female Health Company,(Amex: FHC ) today ... call,to discuss its operating results for the first ... on Wednesday, February 13, 2008. The Company plans,to ... the same day., Shareholders and other interested ...
... asks board member to seek restatement of Beth Israel ... Automation CEO and,director Robert Lepofsky should apply the same ... to his role as Vice,Chairperson of the board of ... (BIDMC), according to labor group 1199 SEIU,United Healthcare Workers ...
... TULSA, Okla., Feb. 6 It takes a team ... That,s the,message of an event scheduled for 10 a.m. ... a significant improvement in Oklahoma,s rates of,early childhood immunizations., ... based on,data from 2005 and 2006, the state improved ...
... Limited, BOSTON, Feb. 6 Patient-Centered Computing,and eHealth: ... will be presented under the auspices of Harvard Medical,School,s ... held,at the Omni Parker House Hotel in Boston, MA ... 2006 event that attracted 120 attendees from,throughout the United ...
... This release is also available in German . ... giant dinosaurs could have lived off more than 100 million years ... to become as large as they did. In actual fact such ... have now been published in the journal ,Proceedings of the Royal ...
Cached Medicine News:Health News:Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:The Female Health Company Schedules First Quarter Conference Call for February 13, 2008 2Health News:Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:State Leaders Recognize Oklahoma's Improvement in Immunization Rankings 2Health News:Innovative eHealth Course to Take Place March 28-30 in Boston, Massachusetts 2Health News:Bonn scientists simulate dinosaur digestion in the lab 2Health News:Bonn scientists simulate dinosaur digestion in the lab 3